AU2001295837A1 - Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis - Google Patents
Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesisInfo
- Publication number
- AU2001295837A1 AU2001295837A1 AU2001295837A AU9583701A AU2001295837A1 AU 2001295837 A1 AU2001295837 A1 AU 2001295837A1 AU 2001295837 A AU2001295837 A AU 2001295837A AU 9583701 A AU9583701 A AU 9583701A AU 2001295837 A1 AU2001295837 A1 AU 2001295837A1
- Authority
- AU
- Australia
- Prior art keywords
- receptor ligands
- methods
- aminoalkylpyrrolidine
- compositions
- synthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24371000P | 2000-10-30 | 2000-10-30 | |
US60243710 | 2000-10-30 | ||
PCT/IB2001/002023 WO2002036560A1 (en) | 2000-10-30 | 2001-10-26 | Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001295837A1 true AU2001295837A1 (en) | 2002-05-15 |
Family
ID=22919809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001295837A Abandoned AU2001295837A1 (en) | 2000-10-30 | 2001-10-26 | Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
Country Status (11)
Country | Link |
---|---|
US (2) | US20040039044A1 (de) |
EP (1) | EP1339677B1 (de) |
JP (1) | JP2004517058A (de) |
AT (1) | ATE315023T1 (de) |
AU (1) | AU2001295837A1 (de) |
BR (1) | BR0115042A (de) |
CA (1) | CA2425286A1 (de) |
DE (1) | DE60116517T2 (de) |
ES (1) | ES2251514T3 (de) |
MX (1) | MXPA03002595A (de) |
WO (1) | WO2002036560A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1300108C (zh) * | 2004-12-29 | 2007-02-14 | 浙江大学 | 1-甲基-2-胺乙基吡咯烷的合成方法 |
EP1875899A1 (de) * | 2006-06-29 | 2008-01-09 | Laboratorios Del Dr. Esteve, S.A. | Verwendugng von Agonisten des 5HT7 Rezeptors in der Behandlung von Schmerzen |
JP5628937B2 (ja) * | 2010-01-05 | 2014-11-19 | スベン ライフ サイエンシズ リミティド | 5−ht6受容体リガンドとしてのスルホン化合物 |
AR080374A1 (es) * | 2010-03-05 | 2012-04-04 | Sanofi Aventis | Procedimiento para la preparcion de 2-(ciclohexilmetil)-n-(2-((2s)-1-metilpirrolidin-2-il) etil)- 1,2,3,4-tetrahidroisoquinolin-7- sulfonamida |
KR20220044492A (ko) * | 2019-06-26 | 2022-04-08 | 엔요 파마 | 3차 아민 유도체 및 바이러스 감염 치료를 위한 이의 용도 |
CN111960983A (zh) * | 2020-08-31 | 2020-11-20 | 南通大学 | 一种n-甲基-3-(1-甲基吡咯烷-3-基)丙-1-胺及其合成方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1584800A (de) * | 1968-09-09 | 1970-01-02 | ||
IL36728A0 (en) * | 1970-05-14 | 1971-06-23 | Richardson Merrell Inc | Substituted pyrrolylmethylamines and their preparation |
FR2319337A1 (fr) * | 1975-07-30 | 1977-02-25 | Fabre Sa Pierre | Gem diaryles possedant une activite antiarythmique utile en therapeutique cardiovasculaire |
DE3835291A1 (de) * | 1988-04-19 | 1989-11-02 | Bayer Ag | 1,3-disubstituierte pyrrolidine |
US5571832A (en) * | 1992-11-13 | 1996-11-05 | The United States Of America As Represented By The Department Of Health And Human Services | Nitrogen-containing cyclohetero alkylamino aryl derivatives for CNS disorders |
WO1999050264A1 (fr) * | 1998-03-30 | 1999-10-07 | Kyowa Hakko Kogyo Co., Ltd. | Derives de quinazoline |
BR0012984A (pt) * | 1999-08-04 | 2002-07-16 | Millennium Pharm Inc | Método para tratar um estado associado com o mc4-r em um mamìfero, composto de ligação ao mc4-r, e, composição farmacêutica |
US6699873B1 (en) * | 1999-08-04 | 2004-03-02 | Millennium Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
AU2868601A (en) * | 2000-01-27 | 2001-08-07 | Ribotargets Ltd | Biaryl compounds, their preparation and their use in therapy |
-
2001
- 2001-10-26 WO PCT/IB2001/002023 patent/WO2002036560A1/en active IP Right Grant
- 2001-10-26 EP EP01976572A patent/EP1339677B1/de not_active Expired - Lifetime
- 2001-10-26 JP JP2002539320A patent/JP2004517058A/ja not_active Abandoned
- 2001-10-26 DE DE60116517T patent/DE60116517T2/de not_active Expired - Fee Related
- 2001-10-26 MX MXPA03002595A patent/MXPA03002595A/es unknown
- 2001-10-26 BR BR0115042-1A patent/BR0115042A/pt not_active IP Right Cessation
- 2001-10-26 US US10/415,546 patent/US20040039044A1/en not_active Abandoned
- 2001-10-26 CA CA002425286A patent/CA2425286A1/en not_active Abandoned
- 2001-10-26 ES ES01976572T patent/ES2251514T3/es not_active Expired - Lifetime
- 2001-10-26 AU AU2001295837A patent/AU2001295837A1/en not_active Abandoned
- 2001-10-26 AT AT01976572T patent/ATE315023T1/de not_active IP Right Cessation
-
2005
- 2005-09-19 US US11/229,816 patent/US20060063932A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE60116517D1 (de) | 2006-03-30 |
MXPA03002595A (es) | 2003-06-30 |
CA2425286A1 (en) | 2002-05-10 |
US20060063932A1 (en) | 2006-03-23 |
BR0115042A (pt) | 2004-02-03 |
EP1339677A1 (de) | 2003-09-03 |
JP2004517058A (ja) | 2004-06-10 |
ES2251514T3 (es) | 2006-05-01 |
EP1339677B1 (de) | 2006-01-04 |
WO2002036560A1 (en) | 2002-05-10 |
ATE315023T1 (de) | 2006-02-15 |
DE60116517T2 (de) | 2006-08-17 |
US20040039044A1 (en) | 2004-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2413424A1 (en) | Substituted bicyclic derivatives for the treatment of abnormal cell growth | |
CA2358998A1 (en) | Substituted bicyclic derivatives useful as anticancer agents | |
CA2290918A1 (en) | Heteroaromatic bicyclic derivatives useful as anticancer agents | |
AP1822A (en) | Substituted pyridinones as modulators of P38 MAP kinase. | |
WO2002024701A3 (en) | Substituted azepino[4,5b)indole derivatives | |
CA2333703A1 (en) | Isothiazole derivatives useful as anticancer agents | |
HK1070054A1 (en) | Arylsulfonyl derivatives with5-ht6 receptor affinity | |
WO2005018557A3 (en) | Substituted pyridinones | |
WO2004020431A3 (en) | Novel benzoimidazole derivatives useful as antiproliferative agents | |
AU2001264474A1 (en) | Admantane derivatives | |
CA2392973A1 (en) | Benzoimidazole derivatives useful as antiproliferative agents | |
NO20015172L (no) | 1-metyl-erytromycin-derivater | |
MY140835A (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists | |
HK1046902A1 (zh) | 新型哌嗪基烷基硫代嘧啶衍生物,包含該衍生物的藥物組合物以及製備該活性物質的方法 | |
AU2001295837A1 (en) | Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis | |
AU6220300A (en) | Benzofurylpiperazine serotonin agonists | |
RS44004A (en) | Processes for the preparation of substituted bicyclid derivatives for the treatment of abnormal cell growth | |
YU46302A (sh) | Supstituisani piroli | |
WO2001083449A3 (en) | Rigid pyrrolidone modulators of pkc | |
AP9801235A0 (en) | Erythromycin derivatives. | |
AP9901559A0 (en) | Tricyclic 3-keto derivatives of 6-0-methylerythromycin. | |
WO2002036554A3 (en) | Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis | |
BG106093A (en) | 14beta-h-sterols, pharmaceutical compositions comprising them and the use of these derivatives for the preparation of meiosis regulating medicaments | |
UA81405C2 (en) | Substituted pyridinones as modulators of p38 map kinase | |
MXPA99003849A (es) | Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina. |